Children under the age of 5 are at a higher risk of pneumococcal infections. The immune systems of young children are not fully developed, making them more susceptible to severe diseases. PCV has been shown to significantly reduce the incidence of these infections, thereby decreasing hospitalizations and mortality rates in this age group.
